The headlines say the space trade is broken. Blue Origin's New Glenn rocket exploded on its launch pad. SpaceX quietly lowered its IPO valuation target from above $2 trillion to at least $1.8 trillion. Jefferies analyst Sheila Kahyaoglu downgraded Rocket Lab and Redwire from Buy to Hold. Rocket Lab stock tumbled more than 15% on Monday, wiping out weeks of gains. If you read the tape, the sector is in free fall.
The cash-flow path says something different. The selloff is treating four companies as if they share one business model. They don't. Two of them are still burning cash with no credible path to cash generation in the next 12 months. One is an options proxy wearing a space costume. One - Rocket Lab - is the only one among them that is actually building a revenue machine and approaching the inflection where free cash flow stops being a distant promise.
The market doesn't care right now. Fear is indiscriminate. But indiscriminate fear is what creates the setups worth sitting on.
The primary driver: Blue Origin's explosion was a supply-chain scare, not a business-model scare.
Blue Origin's New Glenn blew up on the pad on May 29. AST SpaceMobile sank 15% that day because its BlueBird satellite constellation depends on Blue Origin launches. That is a genuine supply-chain risk for ASTS - their satellites can't get to orbit if their launch partner is grounded.
But Rocket Lab doesn't ride Blue Origin. RKLB has its own Electron rocket and is building Neutron, a heavier-lift vehicle for its own commercial and defense contracts. The explosion is noise for Rocket Lab. It isn't for AST SpaceMobile. The market conflated the two, and the tape punished everything equally.
The secondary amplifier: SpaceX's valuation retreat knocked air out of the hype trade.
SpaceX is targeting a June 12 IPO at $135 per share, aiming to raise $75–$80 billion and settle into a valuation of roughly $1.8 trillion. That is lower than the $2 trillion-plus figure Bloomberg reported earlier this year. The downgrade isn't catastrophic, but it punctured the "anything space-adjacent must re-rate" bid.
When the comparison anchor shifts from $2 trillion to $1.8 trillion, the companies that were priced on pure extrapolation feel the drag first. The ones with actual revenue growth absorb it differently.
Now the financial bridge.
Rocket Lab posted $200.3 million in Q1 2026 revenue - up 63.5% year over year. Gross margin hit 38.2%. The backlog sits at $2.2 billion. Revenue for all of 2025 was $602 million, up nearly 38% from 2024. The company is not profitable by GAAP, and free cash flow remains negative as Neutron development eats capital. Those are real constraints.
But AST SpaceMobile reported $14.7 million in Q1 2026 revenue and a $191 million net loss. Free cash flow was negative $427 million in the most recent quarter. Yes, they hold $3.5 billion in cash - but at that burn rate, the runway is short enough to keep investors nervous. They also had a launch failure in April. The business they are selling - a direct-to-cell satellite network - is still years from scale revenue.
Virgin Galactic? Up 18% at $7.28, bucking the selloff. That's not because the business improved. It's because SPCE trades as a lottery ticket. No revenue trajectory, no cash-flow bridge, just momentum and hope.
Redwire, the space infrastructure plays maker, got downgraded to Hold by Kahyaoglu with a $24 price target. Smaller market cap, thinner public disclosure, and more dependent on government contract pacing. It's a real business, but the visibility is lower.
RKLB is the only one in this group where you can trace a line from today's revenue growth to a future where free cash flow actually shows up. That line doesn't exist yet. But it's drawn.
What about the insider selling?
Here's the ugly part. Rocket Lab insiders have sold $687 million worth of stock over the past 24 months. Four executives dumped shares on Monday, right as the selloff started - the largest single sale was $5.96 million. Over the past 90 days, net insider activity is negative $25.5 million.
That's not nothing. Insiders see every spreadsheet. When they sell en masse at record highs, you take note. It suggests the internal view on valuation may not align with the retail euphoria that pushed the stock up 163% over the past year.
But insider selling at peaks is also the most overread signal in markets. People have options that vest, tax bills, and diversified portfolios they need to rebalance. The question isn't whether insiders are selling - they are. The question is whether the revenue acceleration and backlog growth continue even as they do. So far, yes. Q1 was a 63% jump on the strength of it.
I can be wrong again. It has really humbled me in the past to buy a story that looked clean on the surface only to watch cash flow disappoint for three more quarters. Neutron is delayed, development costs are real, and negative free cash flow is not a minor inconvenience when your stock has run this far.
But the setup is specific: revenue is compounding at nearly 65%, the backlog covers the next two years of current run-rate revenue, and the gross margin trajectory is moving in the right direction. If Neutron launches on a somewhat credible timeline - and the company's guidance suggests early 2027 - the margin profile changes materially. A heavier-lift rocket owned by the company, not leased from a competitor, is an operating leverage event.
This isn't about excitement. It's about a business that may soon look a lot harder to dismiss once the cash actually shows up.
What would break the thesis.
Neutron delays beyond late 2027, with no corresponding deceleration in capital intensity. That's the one that matters. If the company keeps spending like a pre-revenue company while revenue growth slows, the story breaks.
A second consecutive quarter of widening losses with no backlog additions would signal the same thing. The $2.2 billion backlog is the floor right now - if that number stops growing, the revenue bridge starts to rot.
Or the simpler version: if the stock keeps selling off on sector noise while the quarterly numbers keep printing, you sit on your hands. Just breathe. The inflection isn't the stock price. It's the cash flow.
The market is still pricing the Blue Origin explosion as a sector event. The numbers say it's a supply-chain event for one company and background noise for another. That gap - between indiscriminate fear and selective fundamentals - is where the next 12 months begin.